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Abstract: The first fully synthetic polymer-based approach for
red-blood-cell cryopreservation without the need for any
(toxic) organic solvents is reported. Highly hydroxylated
block copolymer worms are shown to be a suitable replace-
ment for hydroxyethyl starch as a extracellular matrix for red
blood cells. When used alone, the worms are not a particularly
effective preservative. However, when combined with poly-
(vinyl alcohol), a known ice-recrystallization inhibitor, a re-
markable additive cryopreservative effect is observed that
matches the performance of hydroxyethyl starch. Moreover,
these block copolymer worms enable post-thaw gelation by
simply warming to 20 8C. This approach offers a new solution
for both the storage and transport of red blood cells and also
a convenient matrix for subsequent 3D cell cultures.
Donor cells and tissue are essential components of modern
medicine. For example, 30 million units of blood are annually
transfused in the USA, and up to 100 pints (57 liters) of blood
are required for a single trauma victim.[1] Leukemia treatment
requires donor bone marrow, and emerging regenerative
medicines (e.g., stem-cell treatments) require a constant
supply of cells and the logistical infrastructure to transport
them.[2] However, this is complicated by the finite lifetime of
isolated cells.[3] Red blood cells can be kept for a maximum of
42 days (but typically for shorter periods), platelets for 8 days,
and donor organs for just a matter of hours. In principle,
cryopreservation (freezing to reduce the rate of cellular
degeneration) can be used to enable the storage and transport
of cells and tissue.[4] Current state-of-the-art strategies for
cryopreservation require the addition of large amounts of
water-miscible organic solvents, such as glycerol or DMSO, to
promote vitrification (ice-free state) or dehydration.[5] There
are several problems with this approach, not least solvent
toxicity, and the need (and challenges) of removing all traces
of such solvents before transfusion. There are also many cell
types (for medicine and basic biosciences) that are challeng-
ing to store using current methods.[6]
A major cause of damage in cellular cryopreservation is
attributed to ice recrystallization (growth) during thawing.
Ice-recrystallization inhibitors, such as antifreeze (glyco)pro-
teins (AF(G)Ps), enhance cellular cryopreservation but are
challenging to synthesize and have biocompatibility issues.[7]
Gibson and co-workers have previously described the use of
synthetic polymers as mimics of AF(G)Ps to enhance cell
recovery after thawing.[8] However, in both cases (polymer
and AF(G)P), it was necessary to add a supplementary
extracellular cryoprotectant. Typically, hydroxyethyl starch
(HES) is used as a non-toxic alternative to solvents,[9] but this
biopolymer does not come as a pure product: it has variable
degrees of hydroxyethyl moieties and a broad molecular-
weight distribution. Furthermore, HES has recently been
partially withdrawn from clinical use owing to a possible
increase in mortality for critically ill patients.[10] To the best of
our knowledge, no synthetic mimics of HES have been
evaluated for cryopreservation. Conversely, the use of
synthetic copolymer gels as mimics of the extracellular
matrix for 3D cell cultures is a rapidly developing field.
Armes and co-workers have demonstrated that block copo-
lymer worms are potentially useful matrices for cell culture
studies as they can be readily switched between fluid and gel
phases by a change in temperature, enabling facile steriliza-
tion by cold ultrafiltration.[11]
The aim of this study was to investigate the use of diblock
copolymer worms as wholly synthetic biomimetic alternatives
to HES for cellular cryopreservation and to examine their
additive effects when used in combination with polymeric ice-
recrystallization inhibitors. The feasibility of thermally trig-
gered hydrogelation after thawing, which is highly desirable
for tissue-engineering applications, was also explored.
The first step was to prepare the poly(glycerol mono-
methacrylate)-block-poly(2-hydroxypropyl methacrylate)
(PGMA-PHPMA) block copolymer worms by polymeri-
zation-induced self-assembly (PISA; Figure 1A).[11b] More
specifically, RAFT aqueous dispersion polymerization of
HPMA was conducted using a PGMA56 macro-CTA
(CTA= chain transfer agent) to target PGMA56-PHPMA155
worms, as previously reported by Armes and co-workers (see
the Supporting Information for further experimental and
characterization details).[11a,12] These worm gels exhibited
thermoresponsive behavior, undergoing degelation upon
cooling to 5–10 8C by a reversible worm-to-sphere transi-
tion.[11a] This order–order morphological transformation may
provide a useful trigger for the construction of 3D cell-seeded
gels (see below). Oscillatory rheology studies of a 10% w/w
aqueous worm gel indicated a critical gelation temperature
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(CGT) of approximately 12 8C, as judged by the intersection
of the G’ and G’’ curves (see the Supporting Information,
Figure S3). A representative TEM image obtained upon
drying a dilute aqueous dispersion of PGMA56-PHPMA155
worms at 20 8C is shown in Figure 1B.
Ice recrystallization inhibition (IRI) is a unique (and rare)
property exhibited by certain macromolecules.[13] To evaluate
whether the PGMA56-PHPMA155 worms exhibited IRI
behavior, they were assayed using the standard “splat” test
and compared to poly(vinyl alcohol) (PVA), which is a potent
IRI-active polymer.[14] Briefly, this assay involves creating
a 10 mm thick wafer of small ice crystals, which are then
annealed at ¢6 8C for 30 min before determining the mean
largest grain size (MLGS) of the ice crystals (with smaller ice
crystals indicating higher activity). The results of this assay
are shown in Figure 2A. The PGMA56-PHPMA155 worms
showed no activity even at 20 mgmL¢1, which is comparable
to the negative poly(ethylene glycol) (PEG) control and also
HES (see below). In contrast, PVA is highly active even at
1.0 mgmL¢1, which is consistent with our earlier studies.[8a]
Differential scanning calorimetry studies confirmed that an
aqueous dispersion of PGMA56-PHPMA155 worms does
indeed crystallize when cooled (as indicated by the strong
exotherm at ca. ¢20 8C; in addition, a melting temperature of
around ¢5 8C was also observed). This observation is
important because many current cryopreservation solutions
rely on vitrification by the addition of large quantities of
(toxic) organic solvents. If vitrification had occurred, a much
weaker (or zero) exotherm would have been observed upon
cooling as a result of the formation of a glassy, rather than
a crystalline state.
The above data clearly show that the PGMA56-PHPMA155
worms cause neither ice growth nor nucleation. This makes
them a good candidate to act as wholly synthetic non-
penetrative cryoprotectants like certain biopolymers, such as
hydroxyethyl starch, which can form a hydrated matrix
around cells. Red blood cells were chosen for cryopreserva-
tion studies, as there is an urgent need to improve their long-
term storage without recourse to toxic organic solvents. Our
previous studies had demonstrated that the addition of IRI-
active PVA increases cell recovery by minimizing ice-induced
damage.[8a] Red-blood-cell recovery can be determined by
comparing the relative degree of hemolysis to a positive
control—this serves as a key clinical indicator of their post-
thaw utility. Preliminary screening studies indicated that the
PGMA56-PHPMA155 worms were non-hemolytic towards red
blood cells at concentrations up to 20 mgmL¢1. Accordingly,
a 5 wt% aqueous dispersion of PGMA56-PHPMA155 worms
was added to the red blood cells (5 × 106 cellsmL¢1) in the
Figure 2. Effect of the worms and PVA on ice formation/growth. A) IRI
activity of the worms and PVA. Data reported relative to the PBS
control. Inset images: 500 mm. B) Differential scanning calorimetry of
worm dispersions (20 mgmL¢1) with cooling at 10 8Cmin¢1 and thaw-
ing at 2 8Cmin¢1.
Figure 1. A) Synthetic route for the RAFT aqueous dispersion polymer-
ization of HPMA using a water-soluble PGMA56 macro-CTA to form
PGMA56-PHPMA155 diblock copolymer worms. Such worms form
a soft, free-standing aqueous hydrogel at 20 8C, but undergo a rever-
sible worm-to-sphere transition upon cooling below 12 8C. B) Repre-
sentative TEM image of the PGMA56-PHPMA155 diblock copolymer
worms after drying a dilute aqueous dispersion at 20 8C.
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presence and absence of 1 mgmL¢1 PVA (this optimal PVA
concentration inhibits ice growth without inducing dynamic
ice shaping).[8a] These aqueous mixtures were rapidly frozen
by immersion in liquid nitrogen and stored above liquid N2
for three days, followed by slow thawing at 4 8C. This thawing
protocol was chosen to maximize cell stress, thus providing
a stringent test of the cryopreservative performance of this
new PVA/PGMA56-PHPMA155 worm formulation. It is also
representative of the environment typically used for large-
volume cell freezing for which temperature gradients are
known. Moreover, this thawing temperature ensures that no
worm gel formation occurs, as it is below the CGT of 12 8C.
The results of these freeze–thaw experiments are shown in
Figure 3 relative to PBS and PVA-only controls.
The PGMA56-PHPMA155 worms alone resulted in just
20% cell survival after thawing, which is somewhat lower
than the optimized 40% cell survival achieved in the presence
of HES and not statistically different from that of PBS alone.
The addition of PVA to HES produced a substantial increase
in cell recovery of up to 70%, which is consistent with the
hypothesis that inhibiting ice growth is key to effective
cryopreservation. PVA alone only enabled 40% cell recovery,
highlighting the importance of a secondary hydrated compo-
nent. Remarkably, the addition of PVA to the PGMA56-
PHPMA155 worms gave 68% recovery, which is statistically
indistinguishable to that of the HES/PVA system. There was
no evidence for any hemagglutination or abnormal cell
morphologies. This is the first demonstration that a wholly
synthetic (polymer or otherwise) formulation can be used to
achieve efficient cell cryopreservation. Clearly, there is huge
scope for further optimization as well as the incorporation of
additional functionality, such as cell-adhesion motifs or
fluorescent labels, by rational design. Moreover, the potential
to achieve in situ aqueous gelation immediately after thawing
is highly desirable for tissue-engineering applications (if not
for blood itself). For example, Figure 3B shows digital
photographs of a whole blood sample that had been
cryopreserved, thawed, and then heated above the CGT of
the worms, demonstrating the rapid formation of a gel rich in
red blood cells directly from the cryopreservation mixture
described herein.
In summary, we have demonstrated that diblock copoly-
mer worm gels are the first synthetic alternative to biopoly-
mers (such as hydroxyethyl starch) for the solvent-free
cryopreservation of red blood cells, with particular efficacy
being achieved when combined with an ice-recrystallization
inhibitor such as poly(vinyl alcohol). After initial thawing at
4 8C, the copolymer worms retained their ability to form free-
standing gels upon warming to room temperature, suggesting
an attractive one-pot solution for future whole blood
cryopreservation and tissue-engineering applications.
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